Clinical Trials Browser

Phase 3 × Arthritis, Juvenile × Clear all

NCT02334748 2020-05-19

A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies

Rheumatoid Arthritis, Systemic Juvenile, Bronchiolitis Obliterans Syndrome, Arthritis, Juvenile, Arthralgia, Mevalonate Kinase Deficiency, Cryopyrin-Associated Periodic Syndromes

NCT01206907 2012-08-17

Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects

Phase 3 Withdrawn

Classical hematology

Anemia, Sickle Cell, Arthritis, Juvenile, Neoplasms, Chronic Pain

NCT00964210 2011-04-15

HPV

Phase 3 Completed

240 enrolled

GynecologicLymphoidOther hematologic neoplasm

Arthritis, Juvenile, Uterine Cervical Neoplasms, Inflammatory Bowel Diseases, Renal Insufficiency, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00012506 2005-06-24

The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis

Phase 3 Unknown

Arthritis, Juvenile, Uveitis